Increase in Issued Shares and Capital from Exercise of Stock Acquisition Rights
First written in FY2025-Q1. 4 of 5 entries say "Advanced", first in FY2025-H1. Latest entry: FY2027-H1.
103 other companies' latest entry also says "Advanced".
- FY2027-H1AdvancedAnnual report
「1 March 2026–31 August 2026 (Note) 5,500 21,490,900 9 5,550 9 5,493 (Note) The increases resulted from the exercise of stock acquisition rights.」
During the current interim accounting period, the exercise of stock acquisition rights increased shares by 5,500 and increased share capital and capital surplus by ¥9 million each. - FY2026-H1AdvancedAnnual report
「1 March 2025–27 June 2025 (Note) 1 2,000 21,460,100 3 5,495 3 5,438 28 June 2025–31 August 2025 (Note) 1 5,200 21,470,900 9 5,504 9 5,447 (Note) 1 Increase resulting from the exercise of stock acquisition rights.」
During the current interim accounting period, the exercise of stock acquisition rights increased shares by 7,200 and increased share capital and capital surplus by ¥12 million each. - FY2025AdvancedAnnual report
「1 March 2024–28 February 2025 26,700 21,458,100 47 5,491 47 5,434 (Note) Increase resulting from the exercise of Fourth Series stock acquisition rights.」
During the fiscal year, the exercise of stock acquisition rights increased issued shares by 26,700 and increased share capital and capital surplus by ¥47 million each. - FY2025-H1AdvancedAnnual report
「1 March 2024–31 August 2024 (Note) 22,200 21,453,600 39 5,483 39 5,426 (Note) Increase resulting from the exercise of stock acquisition rights.」
Between 1 March and 31 August 2024, the exercise of stock acquisition rights increased issued shares by 22,200 and increased share capital and capital surplus by ¥39 million each. - FY2025-Q1First statedAnnual report
「1 March 2024–31 May 2024 (Note) 14,600 21,446,000 26 5,470 26 5,413 (Note) Increase resulting from the exercise of stock acquisition rights.」
Between 1 March and 31 May 2024, the exercise of stock acquisition rights increased the number of shares by 14,600 and increased share capital and capital surplus by ¥26 million each.